Insulet Corp. Stock Underperforms Thursday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Insulet Corp. (PODD) shares fell 3.06% to $146.87 on Thursday, underperforming competitors like Eli Lilly and DexCom during a broader market decline. The drop ended a two-day winning streak, with the stock trading 58.61% below its 52-week high of $354.88. Trading volume was lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Insulet Corp. (PODD) slipped 3.06% to $146.87 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.87% to 7,641.16 and Dow Jones Industrial Average falling 1.32% to 52,759.21.
The stock's fall snapped a two-day winning streak.
Insulet Corp. closed 58.61% short of its 52-week high of $354.88, which the company achieved on November 20th.
The stock underperformed when compared to some of its competitors Thursday, as Eli Lilly & Co. (LLY) fell 2.81% to $1,244.40, DexCom Inc. (DXCM) rose 0.38% to $90.22, and Johnson & Johnson (JNJ) fell 2.21% to $267.37.
Trading volume (1.2 M) remained 378,652 below its 50-day average volume of 1.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-20-26 1732ET